Abstract: The technology provided herein relates to high resolution multiplex methods and kits for detecting different analytes in a sample by sequential signal-encoding of said analytes, wherein the method allows a differentiation of targets which distance is below the diffraction limit of optical microscopes, i.e. targets with spatial optical overlap. The disclosed methods also include in vitro methods for screening, identifying and/or testing a substance and/or drug and in vitro methods for diagnosis of a disease, and an optical multiplexing system.
Type:
Application
Filed:
June 14, 2024
Publication date:
December 19, 2024
Applicant:
Resolve BioSciences GmbH
Inventors:
Cheng Frank Zhong, Christian Korfhage, Frank Reinecke, Stephan Tirier
Abstract: The present disclosure pertains to novel multiplex methods and kits for detecting different analytes in a sample in parallel by sequential signal-encoding of said analytes. In particular, the present disclosure pertains to a method that results in inactivation of pathogens for in-situ spatial transcriptomics (e.g. Molecular Cartography) without the step DNA or RNA preparation prior to analysis.
Type:
Application
Filed:
August 4, 2022
Publication date:
November 7, 2024
Applicant:
Resolve BioSciences GmbH
Inventors:
Christian Korfhage, Frank Reinecke, Andreas Geipel
Abstract: The technology provided herein relates to multiplex methods and kits for detecting different analytes and different subgroups/variations of an analyte in a sample, as well as in vitro methods for screening, identifying and/or testing a substance and/or drug and in vitro methods for diagnosis of a disease, and an optical multiplexing system.
Type:
Application
Filed:
June 18, 2021
Publication date:
August 22, 2024
Applicant:
Resolve BioSciences GmbH
Inventors:
Andreas Geipel, Frank Reinecke, Christian Korfhage
Abstract: The technology provided herein relates to high resolution multiplex methods and kits for detecting different analytes in a sample in parallel by sequential signal-encoding of said analytes, wherein the method allows a differentiation of targets which distance is below the diffraction limit of optical microscopes, that is, targets with spatial optical overlap. The disclosed methods also include in vitro methods for screening, identifying and/or testing a substance and/or drug and in vitro methods for diagnosis of a disease, and an optical multiplexing system.
Type:
Application
Filed:
June 29, 2023
Publication date:
May 16, 2024
Applicant:
Resolve Biosciences GmbH
Inventors:
Cheng Frank ZHONG, Christian Korfhage, Frank Reinecke, Stephan Tirier
Abstract: The technology provided herein relates to multiplex methods and kits for detecting different analytes in a sample in parallel by sequential signal-encoding of said analytes, as well as in vitro methods for screening, identifying and/or testing a substance and/or drug and in vitro methods for diagnosis of a disease, and an optical multiplexing system.
Type:
Application
Filed:
June 18, 2021
Publication date:
July 20, 2023
Applicant:
Resolve BioSciences GmbH
Inventors:
Andreas Geipel, Frank Reinecke, Christian Korfhage
Abstract: The present invention is directed to a method of sequential signal-encoding of analytes in a sample, a use of a set of decoding oligonucleotides to sequentially signal-encode analytes in a sample, and to a kit for sequentially signal-encoding of analytes in a sample.
Type:
Application
Filed:
June 18, 2020
Publication date:
July 28, 2022
Applicant:
RESOLVE BIOSCIENCES GMBH
Inventors:
Andreas GEIPEL, Frank REINECKE, Christian KORFHAGE, Nadine JAGEMANN, Vanessa MOELLERING
Abstract: The technology provided herein relates to multiplex methods and kits for detecting different analytes and different subgroups/variations of an analyte in a sample, for example in parallel by sequential signal-encoding of said analytes, as well as in vitro methods for screening, identifying and/or testing a substance and/or drug and in vitro methods for diagnosis of a disease, and an optical multiplexing system.
Type:
Application
Filed:
December 17, 2021
Publication date:
June 30, 2022
Applicant:
Resolve Biosciences GMBH
Inventors:
Andreas GEIPEL, Christian KORFHAGE, Frank REINECKE